[Use of T-activin and prodigiozan in combined treatment of patients with diabetic retinopathy].
Sakalo
E A
EA
Malyzhev
V A
VA
Danilova
A I
AI
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000936:Antigen-Antibody Complex / Q000032:analysis; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D004359:Drug Therapy, Combination; D006801:Humans; D010455:Peptides / Q000008:administration & dosage*; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage*; D011354:Prodigiozan / Q000008:administration & dosage*; D013601:T-Lymphocytes / Q000276:immunology; D013949:Thymus Extracts / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D000936:Antigen-Antibody Complex; D010455:Peptides; D011135:Polysaccharides, Bacterial; D013949:Thymus Extracts; C036191:T-activin; D011354:Prodigiozan
Primenenie taktivina i prodigiozana v kompleksnom lechenii bol'nykh diabeticheskoĭ retinopatieĭ.